{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6909b7a46204e248db2b1b29/69c6ba99f4bf09c599fd0504?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The red-state psychedelic","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6909b7a46204e248db2b1b29/1774631504359-6f4ad48c-7766-4767-b93d-643eba5c9e4e.jpeg?height=200","description":"<p>Ibogaine, a potent psychedelic, is coming to red-state America. Tamara Gilkes Borr meets one of the movement’s most determined advocates, an evangelist on a mission to spread ibogaine across America, to understand why this illegal and potentially dangerous psychedelic is gaining popularity among conservatives.</p><p><br></p><p>Topics covered:</p><ul><li>ibogaine</li><li>psychedelics</li><li>conservatives</li><li>opioid crisis</li><li>Bryan Hubbard</li></ul><p><br></p><p>Links to articles:</p><p><a href=\"https://www.economist.com/united-states/2023/12/30/kentucky-eyes-ibogaine-a-psychedelic-to-treat-opioid-addiction\" rel=\"noopener noreferrer\" target=\"_blank\">Kentucky eyes ibogaine</a></p><p><a href=\"https://www.economist.com/science-and-technology/2026/02/19/a-psychedelic-medicine-performs-well-against-depression\" rel=\"noopener noreferrer\" target=\"_blank\">A psychedelic medicine performs well against depression</a></p><p><a href=\"https://www.economist.com/obituary/2025/06/05/amanda-feilding-fought-to-rescue-the-reputation-of-psychedelics\" rel=\"noopener noreferrer\" target=\"_blank\">Amanda Feilding fought to rescue the reputation of psychedelics</a></p><p><br></p><p><em>Listen to what matters most, from global politics and business to science and technology—</em><a href=\"https://subscribenow.economist.com/podcasts-plus\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Subscribe to Economist Podcasts+</em></a></p><p><br></p><p><em>For more information about how to access Economist Podcasts+, please visit our </em><a href=\"https://myaccount.economist.com/s/article/What-is-Economist-Podcasts\" rel=\"noopener noreferrer\" target=\"_blank\"><em>FAQs page</em></a><em> or watch </em><a href=\"https://www.youtube.com/watch?v=48TlDbL-4vU\" rel=\"noopener noreferrer\" target=\"_blank\"><em>our video</em></a><em> explaining how to link your account.</em></p><p><br></p><p><em>Music by bluedot Sessions and Epidemic Sound.</em></p><p><br></p><p><em>This podcast transcript is generated by third-party AI. It has not been reviewed prior to publication. We make no representations or warranties in relation to the transcript, its accuracy or its completeness, and we disclaim all liability regarding its receipt, content and use. If you have any concerns about the transcript, please email us at podcasts@economist.com.</em></p><p><a href=\"https://myaccount.economist.com/s/article/How-we-handle-AI-generated-content\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Read more about how we are using AI.</em></a></p>","author_name":"The Economist"}